Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Hepatitis Health Center

Font Size

New Hepatitis C Drugs Looking Better

WebMD Health News

April 18, 2002 -- The odds of beating the killer hepatitis C virus are getting better. A new study shows that basing treatment on the specific type of virus improves the odds of becoming virus free.

Those odds now stand at three chances in five overall. People infected with easier-to-treat types of the virus have almost a four-in-five chance of success. Even the hard-to-treat subtype called genotype 1 -- which accounts for 70% of U.S. infections -- responds more than half the time.

Doctors call this kind of success a "sustained viral response." It means that no virus can be found in the blood or the liver for at least six months after treatment. In patients who have had this kind of response, the virus nearly always goes away and stays gone for at least 10 years. Some say it's a cure.

"We are now over 60% sustained viral response for first time in history," says Donald M. Jensen, MD, director of the liver unit at Rush-Presbyterian-St. Luke's Medical Center, Chicago. "Cure is a word we doctors shy away from using. But if there is no virus in the blood or liver and the liver returns to normal, maybe that is the next best thing."

Jensen's report came at the annual meeting of the European Association for the Study of Liver, held this week in Madrid. He led an international study of a new brand of long-lasting interferon -- Pegasys -- given in combination with the hepatitis C drug ribavirin. Pegasys isn't available yet -- U.S. approval is expected this fall -- but a similar drug called PEG-Intron is already on the market.

Jensen's claim that the Pegasys results are the best ever is technically correct. But earlier PEG-Intron studies show similar results if one looks only at patients who got the right ribavirin dosage for their body weight.

The big news from the new study is that not everybody has to suffer through the grueling 48 weeks of full-dose combination treatment. Most people suffer flu-like symptoms from the interferon, and ribavirin -- in addition to other side effects -- is very toxic to blood cells.

Today on WebMD

Hepatitus C virus
Types, symptoms and treatments.
liver illustration
Myths and facts about this essential organ.
woman eating apple
What you need to know.
doctor and patient
What causes it?
Hepatitis C Treatment
Syringes and graph illustration
liver illustration
passport, pills and vaccine
Scientist looking in microscope
Fatty Liver Disease
Digestive Diseases Liver Transplantation
Picture Of The Liver
Image Collection